Academic Medical Education

Academic Medical Education Contactgegevens, kaart en routebeschrijving, contactformulier, openingstijden, diensten, beoordelingen, foto's, video's en aankondigingen van Academic Medical Education, Medisch en gezondheid, Biltstraat 106, Utrecht.

Virology Education | Academic Medical Education (VE | AME) is an established organization dedicated to advancing clinical care and scientific research within the fields of infectious diseases and related disciplines.

๐ŸŒ ๐—”๐—ป๐—ป๐—ผ๐˜‚๐—ป๐—ฐ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐Ÿญ๐˜€๐˜ ๐—”๐˜€๐—ถ๐—ฎ-๐—ฃ๐—ฎ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—›๐—•๐—ฉ ๐—–๐˜‚๐—ฟ๐—ฒ!While intensive research efforts on HBV curative treatments are u...
04/03/2026

๐ŸŒ ๐—”๐—ป๐—ป๐—ผ๐˜‚๐—ป๐—ฐ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐Ÿญ๐˜€๐˜ ๐—”๐˜€๐—ถ๐—ฎ-๐—ฃ๐—ฎ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—›๐—•๐—ฉ ๐—–๐˜‚๐—ฟ๐—ฒ!

While intensive research efforts on HBV curative treatments are underway across Asia and the Pacific, discussions often remain within national programs, with no dedicated regional platform to disseminate data and stimulate collaboration across the region.

For the first time, this workshop aims to change that.

๐—๐—ผ๐—ถ๐—ป ๐˜‚๐˜€ ๐—ถ๐—ป ๐—ฆ๐—ฒ๐—ผ๐˜‚๐—น, ๐—ฆ๐—ผ๐˜‚๐˜๐—ต ๐—ž๐—ผ๐—ฟ๐—ฒ๐—ฎ, for a scientific forum designed to:
โ€ข Provide an Asia-Pacific platform to discuss clinical studies and translational HBV cure research
โ€ข Stimulate long-lasting regional collaborations and research networks
โ€ข Catalyze scientific exchange across academia, clinical practice, biotech, and pharma
โ€ข Explore the latest strategies to achieve HBV functional cure using newly developed agents targeting the immune system or the viral replication cycle
โ€ข Develop endpoints and optimal biomarkers for studies focused on finding a cure for Hepatitis B

๐— ๐—ฒ๐—ฒ๐˜ ๐—ผ๐˜‚๐—ฟ ๐—ฒ๐˜…๐—ฝ๐—ฒ๐—ฟ๐˜ ๐—ฃ๐—ฟ๐—ผ๐—ด๐—ฟ๐—ฎ๐—บ ๐—–๐—ต๐—ฎ๐—ถ๐—ฟ๐˜€ representing leading Asian and international institutions, uniting regional expertise with global scientific experience in HBV cure research.

Whether youโ€™re a researcher, clinician, industry leader, or community advocate, this workshop is your opportunity to help build a stronger regional HBV cure network.

๐Ÿ”— To register or find out more, visit: https://amededu.co/3OVJGT1

๐Ÿ“ข ๐—Ÿ๐—”๐—”๐—œ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ: ๐—ž๐—ฒ๐˜† ๐—จ๐—ฝ๐—ฑ๐—ฎ๐˜๐—ฒ๐˜€ & ๐——๐—ฒ๐—ฎ๐—ฑ๐—น๐—ถ๐—ป๐—ฒ๐˜€ ๐—”๐—ฝ๐—ฝ๐—ฟ๐—ผ๐—ฎ๐—ฐ๐—ต๐—ถ๐—ป๐—ดThe 2nd edition of the Workshop on Long-Acting Anti-Infectives is your o...
03/03/2026

๐Ÿ“ข ๐—Ÿ๐—”๐—”๐—œ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ: ๐—ž๐—ฒ๐˜† ๐—จ๐—ฝ๐—ฑ๐—ฎ๐˜๐—ฒ๐˜€ & ๐——๐—ฒ๐—ฎ๐—ฑ๐—น๐—ถ๐—ป๐—ฒ๐˜€ ๐—”๐—ฝ๐—ฝ๐—ฟ๐—ผ๐—ฎ๐—ฐ๐—ต๐—ถ๐—ป๐—ด

The 2nd edition of the Workshop on Long-Acting Anti-Infectives is your opportunity to connect with global leaders and innovators working on the development, implementation, and scale-up of long-acting and extended-release (LA/ER) anti-infective therapies.

This yearโ€™s program features groundbreaking insights from renowned experts, including:
โ€ข Andrew Owen โ€“ Innovative Modalities for Delivering Long-Acting Antivirals
โ€ข Sunil Solomon โ€“ Behavioral Considerations and Adherence Strategies for People Who Use Drugs, including the injection drug use epidemic in India
โ€ข Jose A Bauermeister โ€“ User Preferences and Considerations in Designing Prevention Strategies
โ€ข Michael Jordan โ€“ Resistance Globally and Its Impact on the Use of Long-acting Antiretrovirals

๐—ช๐—ต๐˜† ๐—ฎ๐˜๐˜๐—ฒ๐—ป๐—ฑ?
Network with peers, join critical debates, and contribute to driving innovation that improves access, adherence, and long-term outcomes in infectious disease care.

Time is running out!
๐Ÿ—“๏ธ ๐—”๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜ ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜€๐˜€๐—ถ๐—ผ๐—ป ๐—ฑ๐—ฒ๐—ฎ๐—ฑ๐—น๐—ถ๐—ป๐—ฒ: 13 March 2026 (just 10 days left!)
โฑ๏ธ ๐—ฆ๐˜๐—ฎ๐—ป๐—ฑ๐—ฎ๐—ฟ๐—ฑ ๐—ฟ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ณ๐—ฒ๐—ฒ ๐—ฒ๐—ป๐—ฑ๐˜€: 14 March 2026

Secure your spot today: https://amededu.co/49Jq0su

26/02/2026

The ๐Ÿฎ๐Ÿณ๐˜๐—ต ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—ผ๐—ณ ๐—›๐—œ๐—ฉ, ๐—›๐—ฒ๐—ฝ๐—ฎ๐˜๐—ถ๐˜๐—ถ๐˜€, ๐—ฎ๐—ป๐—ฑ ๐—ข๐˜๐—ต๐—ฒ๐—ฟ ๐—”๐—ป๐˜๐—ถ๐˜ƒ๐—ถ๐—ฟ๐—ฎ๐—น ๐——๐—ฟ๐˜‚๐—ด๐˜€ will take place in ๐— ๐—ผ๐—ป๐˜๐—ฟรฉ๐—ฎ๐—น, ๐—–๐—ฎ๐—ป๐—ฎ๐—ฑ๐—ฎ in 2026!

This meeting has a special history in Canada โ€” last hosted in Quรฉbec in 2005 (some of you may still remember the snowstorm โ„๏ธ!).

Hear from our local chair, Nancy Sheehan, who has been attending this workshop since 2003, and describes it as the reference meeting in ๐—ฐ๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฝ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—ฎ๐—ป๐—ฑ ๐—ฝ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐—ธ๐—ถ๐—ป๐—ฒ๐˜๐—ถ๐—ฐ๐˜€ for researchers, pharmacists, and physicians.

The workshop covers far more than HIV alone, with a strong focus on B, C, and D, and other viral infections including COVID-19 and .

Expect plenary sessions from internationally renowned keynote speakers, presentations of new research findings, and plenty of opportunities to connect and collaborate!

๐Ÿ—“๏ธ ๐—”๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜ ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜€๐˜€๐—ถ๐—ผ๐—ป๐˜€ ๐—ฎ๐—ฟ๐—ฒ ๐—ป๐—ผ๐˜„ ๐—ผ๐—ฝ๐—ฒ๐—ป, and we warmly encourage you to share your work and be part of the 2026 edition.

๐Ÿ”— More information and key dates: https://amededu.co/3Mk5zdW



Penta ID Ontario HIV Treatment Network (OHTN) HIV Pharmacy Association Clinton Health Access Initiative BCN Checkpoint Hepatitis Foundation of Ghana University of Liverpool

  naar 29 januari 2026 โ€” toen meer dan 40 deelnemers samenkwamen voor de workshop Langwerkende Injectietherapie!Dank aan...
25/02/2026

naar 29 januari 2026 โ€” toen meer dan 40 deelnemers samenkwamen voor de workshop Langwerkende Injectietherapie!

Dank aan alle betrokken deelnemers, inspirerende sprekers en toegewijde commissieleden voor een dag vol nieuwe inzichten, prikkelende gesprekken en waardevolle verbindingen.

Hoogtepunten uit het programma:
๐Ÿ”นMarcia Valette over ervaringen en uitdagingen met langwerkende injectietherapie
๐Ÿ”นDr. Piter Oosterhof over financiering
๐Ÿ”นDr. Ferdinand Wit met de nieuwste EACS-data
๐Ÿ”นProf. dr. David Burger over farmacologische vraagstukken
๐Ÿ”นDr. Anne Wensing over virologisch falen, resistentie en behandelopties
๐Ÿ”นAfsluitend panel onder leiding van Dr. Judith Branger over preventie

Gemist of sessies opnieuw bekijken? Presentaties en opnames zijn beschikbaar: https://amededu.co/3XQVzLa

๐Ÿšจ Abstract Submission Deadline: 6 March 2026Have new data on HIV or viral hepatitis?Working on treatment options, resist...
24/02/2026

๐Ÿšจ Abstract Submission Deadline: 6 March 2026

Have new data on HIV or viral hepatitis?
Working on treatment options, resistance, or clinical implementation?

The ๐Ÿฎ๐Ÿฐ๐˜๐—ต ๐—˜๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ฒ๐—ฎ๐—ป ๐— ๐—ฒ๐—ฒ๐˜๐—ถ๐—ป๐—ด ๐—ผ๐—ป ๐—›๐—œ๐—ฉ & ๐—›๐—ฒ๐—ฝ๐—ฎ๐˜๐—ถ๐˜๐—ถ๐˜€ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ is your opportunity to present your work to an international audience.

Share your latest findings in:
โ€ข Novel Diagnostic Technologies & Approaches
โ€ข Clinical Implications of Antiviral Drug Resistance
โ€ข Drug resistance
โ€ข Clinical Cases
โ€ข And more!

Don't miss the opportunity to contribute to this yearโ€™s scientific programme!
๐Ÿ‘‰ Reduced registration fees are available for abstract submitters!

๐—ฃ๐—น๐—ฎ๐—ป๐—ป๐—ถ๐—ป๐—ด ๐˜๐—ผ ๐—ฎ๐˜๐˜๐—ฒ๐—ป๐—ฑ, ๐—ฒ๐˜ƒ๐—ฒ๐—ป ๐˜„๐—ถ๐˜๐—ต๐—ผ๐˜‚๐˜ ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜๐˜๐—ถ๐—ป๐—ด ๐—ฎ๐—ป ๐—ฎ๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜?
โณ The standard registration fee deadline is 31 March 2026
โœ”๏ธ Save โ‚ฌ100 before late registration fee kicks in

๐Ÿ”— For more information: https://amededu.co/48PPyW3


While proven HIV interventions exist, ๐—ฏ๐—ฎ๐—ฟ๐—ฟ๐—ถ๐—ฒ๐—ฟ๐˜€ ๐—ฎ๐˜ ๐˜๐—ต๐—ฒ ๐˜€๐˜†๐˜€๐˜๐—ฒ๐—บ-, ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ถ๐—ฑ๐—ฒ๐—ฟ-, ๐—ฎ๐—ป๐—ฑ ๐—ฐ๐—ผ๐—บ๐—บ๐˜‚๐—ป๐—ถ๐˜๐˜†-๐—น๐—ฒ๐˜ƒ๐—ฒ๐—น๐˜€ ๐—ฐ๐—ผ๐—ป๐˜๐—ถ๐—ป๐˜‚๐—ฒ ๐˜๐—ผ ๐—น๐—ถ๐—บ๐—ถ๐˜ ๐—ฒ๐—พ๐˜‚๐—ถ๐˜๐—ฎ๐—ฏ...
23/02/2026

While proven HIV interventions exist, ๐—ฏ๐—ฎ๐—ฟ๐—ฟ๐—ถ๐—ฒ๐—ฟ๐˜€ ๐—ฎ๐˜ ๐˜๐—ต๐—ฒ ๐˜€๐˜†๐˜€๐˜๐—ฒ๐—บ-, ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ถ๐—ฑ๐—ฒ๐—ฟ-, ๐—ฎ๐—ป๐—ฑ ๐—ฐ๐—ผ๐—บ๐—บ๐˜‚๐—ป๐—ถ๐˜๐˜†-๐—น๐—ฒ๐˜ƒ๐—ฒ๐—น๐˜€ ๐—ฐ๐—ผ๐—ป๐˜๐—ถ๐—ป๐˜‚๐—ฒ ๐˜๐—ผ ๐—น๐—ถ๐—บ๐—ถ๐˜ ๐—ฒ๐—พ๐˜‚๐—ถ๐˜๐—ฎ๐—ฏ๐—น๐—ฒ ๐—ฎ๐—ฐ๐—ฐ๐—ฒ๐˜€๐˜€ ๐˜๐—ผ ๐—ฝ๐—ฟ๐—ฒ๐˜ƒ๐—ฒ๐—ป๐˜๐—ถ๐—ผ๐—ป ๐—ฎ๐—ป๐—ฑ ๐˜๐—ฟ๐—ฒ๐—ฎ๐˜๐—บ๐—ฒ๐—ป๐˜ ๐˜€๐—ฒ๐—ฟ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€.

From PrEP and ART to self-testing and long-acting injectables, the tools are available. The challenge lies in ensuring their equitable, sustainable, and scalable delivery in real-world settings.

This is where implementation science is essential: by producing evidence on how and why interventions are delivered effectively, adapted to routine health care and public health settings, and translated into meaningful population-level impact.

The ๐Ÿญ๐˜€๐˜ ๐—›๐—œ๐—ฉ, ๐—œ๐—ป๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐˜‚๐˜€ ๐——๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ๐˜€ & ๐—š๐—น๐—ผ๐—ฏ๐—ฎ๐—น ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต ๐—ฆ๐—ฐ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ณ ๐—œ๐—บ๐—ฝ๐—น๐—ฒ๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—–๐—ผ๐—ป๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐—ฐ๐—ฒ (๐—ฉ๐—œ๐—ฆ๐—ง๐—”) focuses on examining how evidence becomes practice and how health systems can better serve those most often left behind.

VISTA will feature ground-breaking presentations across four key themes:
๐Ÿ”น Expanding reach to underserved populations
๐Ÿ”น Integrating and sustaining public health strategies
๐Ÿ”น Making next-generation technologies work in practice
๐Ÿ”น Strengthening global implementation research methods

๐Ÿ“ Cape Town, South Africa
๐Ÿ—“ Updated dates: 21-23 September 2026

The abstract submission deadline has been extended to 26 June 2026!

๐Ÿ”— Learn more: https://amededu.co/3WZw6Pz

Taking place on ๐Ÿญ๐Ÿฌโ€“๐Ÿญ๐Ÿญ ๐—”๐—ฝ๐—ฟ๐—ถ๐—น ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ, the ๐Ÿญ๐Ÿฒ๐˜๐—ต ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—ช๐—ผ๐—บ๐—ฒ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—›๐—œ๐—ฉ offers a dedicated space for scientif...
19/02/2026

Taking place on ๐Ÿญ๐Ÿฌโ€“๐Ÿญ๐Ÿญ ๐—”๐—ฝ๐—ฟ๐—ถ๐—น ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ, the ๐Ÿญ๐Ÿฒ๐˜๐—ต ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—ช๐—ผ๐—บ๐—ฒ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—›๐—œ๐—ฉ offers a dedicated space for scientific exchange on the most pressing issues affecting women living with or at risk of HIV.

This yearโ€™s program addresses urgent global challenges, including ๐—บ๐—ถ๐—ด๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—›๐—œ๐—ฉ, the impact of recent ๐—ณ๐˜‚๐—ป๐—ฑ๐—ถ๐—ป๐—ด ๐—ฐ๐˜‚๐˜๐˜€ on the global HIV response, and the latest evidence-based care guidelines for women during ๐—ฝ๐—ฟ๐—ฒ๐—ด๐—ป๐—ฎ๐—ป๐—ฐ๐˜† ๐—ฎ๐—ป๐—ฑ ๐—ฏ๐—ฟ๐—ฒ๐—ฎ๐˜€๐˜๐—ณ๐—ฒ๐—ฒ๐—ฑ๐—ถ๐—ป๐—ด.

Discussions will also span HIV prevention, gender-based violence, substance use and health access, aging with HIV, and long-acting antiretroviral therapies.

This workshop educates healthcare professionals to better support women living with or at risk of HIV, fostering women's involvement in research and decision-making at all levels.

๐Ÿ”— Explore the preliminary program and learn more about the meeting: https://amededu.co/3V2iGRF

12/02/2026

One month left to ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜ ๐˜†๐—ผ๐˜‚๐—ฟ ๐—ฎ๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜ for the ๐Ÿฎ๐—ป๐—ฑ ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—Ÿ๐—ผ๐—ป๐—ด-๐—”๐—ฐ๐˜๐—ถ๐—ป๐—ด ๐—”๐—ป๐˜๐—ถ-๐—œ๐—ป๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ๐˜€, taking place in ๐—ฃ๐—ต๐—ถ๐—น๐—ฎ๐—ฑ๐—ฒ๐—น๐—ฝ๐—ต๐—ถ๐—ฎ, ๐—ฃ๐—”, ๐—จ๐—ป๐—ถ๐˜๐—ฒ๐—ฑ ๐—ฆ๐˜๐—ฎ๐˜๐—ฒ๐˜€.

The upcoming edition will expand discussions around ๐—น๐—ผ๐—ป๐—ด-๐—ฎ๐—ฐ๐˜๐—ถ๐—ป๐—ด ๐˜๐—ฟ๐—ฒ๐—ฎ๐˜๐—บ๐—ฒ๐—ป๐˜ ๐—ฎ๐—ป๐—ฑ ๐—ฝ๐—ฟ๐—ฒ๐˜ƒ๐—ฒ๐—ป๐˜๐—ถ๐—ผ๐—ป ๐˜€๐˜๐—ฟ๐—ฎ๐˜๐—ฒ๐—ด๐—ถ๐—ฒ๐˜€, community engagement, and real-world implementation across a broad range of infectious diseases.

๐ŸŽฅ In this video, Dr. Charles Flexner, a member of the meeting's Organizing Committee looks back at the first workshop, highlighting discussions on HIV, , , ๐—ต๐—ฒ๐—ฝ๐—ฎ๐˜๐—ถ๐˜๐—ถ๐˜€ ๐—• & ๐—–, and other IDs, and shares what participants can expect from the second edition.

Would you like to share your research on the development, implementation, and scale-up of long-acting and extended-release (LA/ER) anti-infective therapies?

๐Ÿ—“๏ธ Abstracts are due by ๐—™๐—ฟ๐—ถ๐—ฑ๐—ฎ๐˜†, ๐Ÿญ๐Ÿฏ ๐— ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ

Topics for submission include:
โ€ข Future directions and novel platforms for Long-Acting Anti-Infective Therapies
โ€ข Long-Acting Anti-Infectives for key populations
โ€ข Long-Acting formulations for treatment of infections
โ€ข Monoclonal Antibodies
โ€ข Prevention of key infections with Long-Acting Formulations
โ€ข Regulatory, end-User, and implementation issues

๐Ÿ”— More information: https://amededu.co/49Jq0su


Ontario HIV Treatment Network (OHTN) HIV Pharmacy Association Institute on Digital Health and Innovation Hepatitis B Foundation

The ๐Ÿญ๐Ÿฌ๐˜๐—ต ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—”๐—ฑ๐—ผ๐—น๐—ฒ๐˜€๐—ฐ๐—ฒ๐—ป๐—ฐ๐—ฒ, ๐—ฆ๐—ฅ๐—›๐—ฅ & ๐—›๐—œ๐—ฉ marks a milestone year with a new location โ€” Bangkok, Thailan...
10/02/2026

The ๐Ÿญ๐Ÿฌ๐˜๐—ต ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—”๐—ฑ๐—ผ๐—น๐—ฒ๐˜€๐—ฐ๐—ฒ๐—ป๐—ฐ๐—ฒ, ๐—ฆ๐—ฅ๐—›๐—ฅ & ๐—›๐—œ๐—ฉ marks a milestone year with a new location โ€” Bangkok, Thailand!

For the first time, the workshop comes to Asia, bringing together researchers, healthcare professionals, policymakers, implementers, funders, and young people to explore key scientific and programmatic questions around adolescent SRHR and HIV.

This anniversary edition places a strong focus on research and evidence-informed solutions, alongside:
โ€ข Practical, skills-building sessions
โ€ข Digital and next-generation approaches to adolescent engagement
โ€ข Meaningful youth participation โ€” with 40% of attendees under 30
โ€ข A rare, balanced space where different generations and disciplines learn from each other

๐Ÿ”ฌ ๐—–๐—ฎ๐—น๐—น ๐—ณ๐—ผ๐—ฟ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—”๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜๐˜€
We invite submissions from those working to improve SRHR and HIV outcomes for adolescents and young people.

๐Ÿ—“๏ธ Submit your (research) abstract by Friday, 5 June 2026
๐Ÿ”— For full guidelines and submission topics: https://amededu.co/46EBigE


๐—Ÿ๐—ฎ๐˜€๐˜ ๐—ฐ๐—ต๐—ฎ๐—ป๐—ฐ๐—ฒ ๐˜๐—ผ ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜ ๐˜†๐—ผ๐˜‚๐—ฟ ๐—ฎ๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜ ๐—ณ๐—ผ๐—ฟ ๐˜๐—ต๐—ฒ ๐Ÿฏ๐—ฟ๐—ฑ ๐—–๐—ผ๐—ป๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ป ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€ ๐—ถ๐—ป ๐—ง๐˜‚๐—ฏ๐—ฒ๐—ฟ๐—ฐ๐˜‚๐—น๐—ผ๐˜€๐—ถ๐˜€!๐Ÿ—“ Abstract submission deadline...
04/02/2026

๐—Ÿ๐—ฎ๐˜€๐˜ ๐—ฐ๐—ต๐—ฎ๐—ป๐—ฐ๐—ฒ ๐˜๐—ผ ๐˜€๐˜‚๐—ฏ๐—บ๐—ถ๐˜ ๐˜†๐—ผ๐˜‚๐—ฟ ๐—ฎ๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜ ๐—ณ๐—ผ๐—ฟ ๐˜๐—ต๐—ฒ ๐Ÿฏ๐—ฟ๐—ฑ ๐—–๐—ผ๐—ป๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ป ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€ ๐—ถ๐—ป ๐—ง๐˜‚๐—ฏ๐—ฒ๐—ฟ๐—ฐ๐˜‚๐—น๐—ผ๐˜€๐—ถ๐˜€!

๐Ÿ—“ Abstract submission deadline: Friday, ๐Ÿญ๐Ÿฏ ๐—™๐—ฒ๐—ฏ๐—ฟ๐˜‚๐—ฎ๐—ฟ๐˜† ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ

As a pre-meeting to INTEREST Conference, it offers a dedicated platform for tuberculosis research with a strong focus on African settings.

Despite being the worldโ€™s leading infectious killer, tuberculosis research and innovation are still largely discussed in global forums, with too little attention given to the regions bearing the greatest burden.

The 3rd Conference on Innovations in Tuberculosis is an ๐—ฎ๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜-๐—ฑ๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ป ๐—ฒ๐˜ƒ๐—ฒ๐—ป๐˜, where global experts gather to share research and discuss how new approaches can be implemented in African contexts, reflecting local epidemic patterns and healthcare settings.

Would you like to be part of this discussion?

๐Ÿ”— Submit your abstract: https://amededu.co/48MIIQp

P.S. Early-career professionals and attendees from resource-limited settings with an accepted abstract can benefit from registration discounts

Abstract submission is open for the ๐Ÿญ๐Ÿด๐˜๐—ต ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—ฃ๐—ฒ๐—ฑ๐—ถ๐—ฎ๐˜๐—ฟ๐—ถ๐—ฐ๐˜€ & ๐—›๐—œ๐—ฉ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ, taking place this year in ๐—ฅ๐—ถ๐—ผ ...
03/02/2026

Abstract submission is open for the ๐Ÿญ๐Ÿด๐˜๐—ต ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—ฃ๐—ฒ๐—ฑ๐—ถ๐—ฎ๐˜๐—ฟ๐—ถ๐—ฐ๐˜€ & ๐—›๐—œ๐—ฉ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ, taking place this year in ๐—ฅ๐—ถ๐—ผ ๐—ฑ๐—ฒ ๐—๐—ฎ๐—ป๐—ฒ๐—ถ๐—ฟ๐—ผ, ๐—•๐—ฟ๐—ฎ๐˜‡๐—ถ๐—น, ahead of .

The Pediatrics & HIV Workshop aims to stimulate research that advances HIV prevention and treatment for infants, children, and adolescents, and to provide a platform for discussion of the latest developments in pediatric and perinatal HIV.

๐Ÿ—“ Abstract submission deadline: Friday, 17 April 2026
๐Ÿ“Œ Co-submission with AIDS 2026 is allowed

60% of oral abstracts presented at past workshops have resulted in ๐˜€๐—ฐ๐—ถ๐—ฒ๐—ป๐˜๐—ถ๐—ณ๐—ถ๐—ฐ ๐—ฝ๐˜‚๐—ฏ๐—น๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€! Could your research be among the next to result in publication?

๐Ÿ”— Submit your abstract: https://amededu.co/49Zyjlt

Our latest accredited HIV 24/7 e-learning initiative, ๐—œ๐—บ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ถ๐—ป๐—ด ๐— ๐—ฒ๐˜๐—ฎ๐—ฏ๐—ผ๐—น๐—ถ๐—ฐ ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต ๐—ถ๐—ป ๐—ฃ๐—Ÿ๐—ช๐—›๐—œ๐—ฉ โ€“ ๐—ง๐—ฎ๐—ธ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—ก๐—ฒ๐˜…๐˜ ๐—ฆ๐˜๐—ฒ๐—ฝ, addre...
29/01/2026

Our latest accredited HIV 24/7 e-learning initiative, ๐—œ๐—บ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ถ๐—ป๐—ด ๐— ๐—ฒ๐˜๐—ฎ๐—ฏ๐—ผ๐—น๐—ถ๐—ฐ ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต ๐—ถ๐—ป ๐—ฃ๐—Ÿ๐—ช๐—›๐—œ๐—ฉ โ€“ ๐—ง๐—ฎ๐—ธ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—ก๐—ฒ๐˜…๐˜ ๐—ฆ๐˜๐—ฒ๐—ฝ, addresses the management of metabolic complications in people living with HIV.

This self-paced program covers:
โ€ข Why does it matter to manage the excessive visceral fat?
โ€ข How to detect and monitor it?
โ€ข Which therapeutic options are available?

This activity is jointly accredited by Accreditation Council for Continuing Medical Education - ACCME, ACPE, and ANCC - American Nurses Credentialing Center, providing continuing education for clinicians and other healthcare professionals.

๐Ÿ‘‰ Access the course: https://amededu.co/48jvZF9

Adres

Biltstraat 106
Utrecht
3572BJ

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Academic Medical Education nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Delen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Who are we?

Virology Education is the leading provider of top quality, educational and scientific programs in the field of infectious diseases & beyond. Our long-standing relationship with the worldโ€™s leading experts helps us to facilitate the development of high profile and innovative events tailored to the needs of healthcare professionals. Latest developments are disseminated in a scientific and interactive environment in order to reach consensus, translate findings and determine the best strategy forward. Activities include the initiation and organization of live and online platforms for international interchange, knowledge sharing and education.

Together with our sister company, Expert Medical Events, we have focused programs in the fields of: HIV, HCV HBV, Coinfections, Tuberculosis, Emerging Viruses, NASH/ Liver Disease, Pharmacology, Oncology

We are committed to providing uncompromising quality and continuous updates on the most recent medical & scientific developments. Speakers, content and learning objectives are carefully monitored and controlled for quality and effectiveness.